Syschem (India) Limited (SYSCHEM) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE121D01036
Key metrics
- Market Cap
- ₹166 Cr
- P/E Ratio
- 24.9
- EPS
- 1.27
- Book Value
- 24.98
- P/B Ratio
- 1.24
- ROE
- 8.93%
- ROCE
- 13.86%
- Debt / Equity
- 0
- Net Margin
- 1.67%
- Revenue Growth
- 69.49%
- Profit Growth
- 2,275.35%
- Dividend Yield
- —
- 52W High
- ₹61.49
- 52W Low
- ₹29.29
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Syschem (India) Limited
Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialty solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and is based in Chandigarh, India.
- Headquarters
- Chandigarh, India
- Promoter Holding
- 76.13%
The full Syschem (India) Limited analysis
Create a free account to open the complete SYSCHEM deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.